Cytokine release syndrome caused by dual immunotherapy with tremelimumab and durvalumab: A case report

Cytokine release syndrome (CRS) is an acute systemic inflammatory syndrome characterized by fever and organ dysfunction. CRS is increasingly recognized as an immune-related adverse event caused by the use of immune checkpoint inhibitors (ICIs) to treat solid organ tumors. Herein, we report a life-th...

Descripció completa

Dades bibliogràfiques

Autors principals:	Takanori Ito, Saiki Yoshimura, Osamu Kanai, Naoki Fujimoto, Takuma Imakita, Issei Oi, Kohei Fujita, Kiminobu Tanizawa
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-01-01
Col·lecció:	Respiratory Medicine Case Reports
Matèries:	Cytokine release syndrome Immune checkpoint inhibitors Immune-related adverse events Tremelimumab Immunoglobulin G2 POSEIDON regimen
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2213007125001194
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!